John Valliant is CEO at Fusion Pharmaceuticals Inc. (FUSN). They have made 7 open-market trades across 1 company since 2022, most recently 2024-06-04.
CIK 0001813574
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FUSN | 318,147 | $6.9M |
Shares reported on the most recent Form 4, priced at the 2022-04-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FUSN | SELL · 10b5-1 | 2022-04-25 | 2022-04-27 | $6.04 | $53K | -23.1% | -32.2% | -54.4% |
| FUSN | SELL · 10b5-1 | 2022-04-20 | 2022-04-22 | $6.01 | $8K | -17.7% | -36.1% | -59.5% |
| FUSN | SELL | 2022-04-11 | 2022-04-13 | $6.85 | $432K | -6.3% | -30.6% | -57.1% |
| FUSN | SELL · 10b5-1 | 2022-04-06 | 2022-04-08 | $7.55 | $16K | -21.1% | -45.6% | -66.5% |
| FUSN | SELL · 10b5-1 | 2022-04-01 | 2022-04-05 | $7.72 | $29K | -26.0% | -35.4% | -67.6% |
| FUSN | SELL · 10b5-1 | 2022-03-30 | 2022-04-01 | $7.52 | $2K | -23.7% | -34.3% | -68.3% |
| FUSN | SELL | 2022-03-25 | 2022-03-29 | $7.54 | $78K | -0.8% | -32.2% | -65.4% |
| FUSN | SELL · 10b5-1 | 2022-03-21 | 2022-03-24 | $7.52 | $36K | +3.0% | -20.1% | -56.1% |
| FUSN | SELL · 10b5-1 | 2022-03-17 | 2022-03-21 | $7.53 | $27K | +3.5% | -20.8% | -56.7% |
| FUSN | SELL · 10b5-1 | 2022-03-14 | 2022-03-16 | $6.97 | $10K | +6.3% | -23.3% | -50.9% |
| FUSN | SELL · 10b5-1 | 2022-03-09 | 2022-03-14 | $7.03 | $20K | +4.0% | -16.9% | -49.0% |
| FUSN | SELL | 2022-03-04 | 2022-03-08 | $7.17 | $104K | +1.8% | +5.7% | -49.2% |
| FUSN | SELL | 2022-03-01 | 2022-03-03 | $7.44 | $403K | -2.3% | +8.1% | -51.0% |
| FUSN | SELL | 2022-02-24 | 2022-02-28 | $7.53 | $165K | -4.3% | +5.0% | -50.4% |
| FUSN | SELL | 2022-02-18 | 2022-02-23 | $7.78 | $526K | -4.9% | +3.0% | -48.5% |
| FUSN | SELL | 2022-02-15 | 2022-02-17 | $8.04 | $649K | -5.2% | -5.2% | -50.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.